FindTrial
Sign In

Randomised Controlled Trial of Intravitreal Triamcinolone in Patients with Diabetic Macular Oedema Refractory to Laser Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN90614292
Enrollment
Unknown
Registered
2004-09-30
Start date
2003-11-28
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases: Diabetic macular oedema Eye Diseases Diabetic macular oedema

Interventions

1. Intravitreal injection of tiamcinolone 2. Placebo As of March 2008: trial abandoned due to poor recruitment.

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Pre-injection and then month 1, 3 and 6 1. Best corrected visual acuity (logarithm of the minimum angle of resolution [logMAR]) at each visit. A change in either direction of 10 letters on the logMAR chart would be considered significant 2. Near vision tested with a standard add on each visit, with time taken to read the standard N paragraph and the number of mistakes made 3. Intra-ocular pressure at each visit - measured by standard applanation tonometry—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026